We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BMS Recalls Maxipime Antibiotic Over Potential Sterility Issues
BMS Recalls Maxipime Antibiotic Over Potential Sterility Issues
September 8, 2009
Bristol-Myers Squibb (BMS) is recalling 50,440 vials of its broad-spectrum B-lactam antibiotic Maxipime because of a potential lack of sterility assurance related to the vial caps.